)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
India's five listed REITs distributed over Rs 2,450 crore to 380,000 unitholders in Q3 FY26, backed by strong leasing momentum, improving occupancies and regulatory moves expanding access to capital
The pharmaceuticals department has invited stakeholder comments on proposed changes to the list of 350-plus medical devices exempt from GTE rules, with submissions open until February
Homes priced above ₹3 crore saw a 58% rise in lead-to-buy conversion time in 2025 as buyers became more selective, even as overall housing conversion time fell 18% due to faster big-ticket purchases
The steady migration of affluent households from other parts of Delhi towards South Delhi, driven by its superior social infrastructure, iconic value and lifestyle offering, has boosted demand
Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore
Joint centre, initiated by Union Education Ministry, will build scalable, human-centric AI systems for manufacturing sectors including semiconductors and robotics
Education Minister Dharmendra Pradhan chairs AI roundtable with edtech founders ahead of launch of IIT Madras-anchored Bharat Bodhan AI Foundation
Health Ministry proposes removing provisional registration for ethics committees, shifting to single-stage approval to streamline clinical research and cut regulatory delays
Industry executives say the US-Bangladesh reciprocal trade agreement is unlikely to materially affect India's pharma and medtech exports, given India's scale and established FDA-approved supply chains
CBSE has announced the introduction of on-screen marking for Class 12 board exams from February 17, aiming to improve efficiency, transparency and reduce time and logistical costs
IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale
Revised FAR/FSI limits, height relaxations lead to increased investor interest
Domestic device makers warn of safety and dumping risks, while MNC bodies back affordability benefits as the Centre reviews policy on refurbished high-end medical device imports
Pharma-focused Budget 2026 measures could help India move beyond generics by boosting biologics, biosimilars, regulatory capacity and early-stage innovation, analysts say
Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities
Doctors also point to declining professional dignity, workplace violence and medico-legal vulnerability as deterrents
India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access
Industry executives note that REITs raise debt by issuing securities subscribed to by mutual funds and non-banking financial companies (NBFCs)
India's higher education sector could require nearly 30,000 acres of new campus land and 2.7 billion sq ft of academic infrastructure by 2035, driven by rising enrolments and policy ambitions
Max Healthcare's Q3 profit rose 26% on higher occupancies and overseas patients, even as margins narrowed due to regulatory changes and expansion costs